Dual role of natural molecules in bridging cancer and Alzheimer’s disease: insights from in silico simulations

Dual role of natural molecules in bridging cancer and Alzheimer’s disease: insights from in silico simulations

Cancer and Alzheimer's disease (AD) present significant socioeconomic challenges and remain without definitive cures. Existing chemotherapeutic and anti-Alzheimer drugs approved by the FDA offer limited efficacy and carry notable side effects, underscoring the need for safer, more effective th...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nigar Kantarci-Carsibasi, Munteha Girgin
Format:	Article
Language:	English
Published:	Tunç ÇATAL 2024-11-01
Series:	The European Chemistry and Biotechnology Journal
Subjects:	breast cancer Queuine Galantamine molecular docking virtual screening
Online Access:	https://euchembioj.com/index.php/pub/article/view/39
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Galantamine–Curcumin Hybrid Inhibits Butyrylcholinesterase: A Molecular Dynamics Study
by: Evdokiya Salamanova, et al.
Published: (2024-12-01)

Biosynthesis of plant neuroactive alkaloids treating Alzheimer’s disease
by: Quanyu Yin, et al.
Published: (2025-02-01)

In-Silico discovery of 17alpha-hydroxywithanolide-D as potential neuroprotective allosteric modulator of NMDA receptor targeting Alzheimer’s disease
by: Manoj Kumar Vashisth, et al.
Published: (2024-11-01)

Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
by: Rimsha Timotheous, et al.
Published: (2025-01-01)

Exploration of cyclooxygenase-2 inhibitory peptides from walnut dreg proteins based on in silico and in vitro analysis
by: Zishan Hong, et al.
Published: (2024-05-01)

An In Silico Approach to Discover Efficient Natural Inhibitors to Tie Up Epstein–Barr Virus Infection
by: Ayan Das, et al.
Published: (2024-10-01)

Using computer modeling to find new LRRK2 inhibitors for parkinson’s disease
by: María C. García, et al.
Published: (2025-02-01)

Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors
by: Mohamed A. Kotb, et al.
Published: (2024-11-01)

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking
by: In Won Lee, et al.
Published: (2017-12-01)

Finding potential inhibitors from phytochemicals against nucleoprotein of crimean congo fever virus using in silico approach
by: Muhammad Ramzan, et al.
Published: (2024-12-01)

Studi In Silico Aktivitas Senyawa Steroid Terhadap Antikanker Payudara Menggunakan Estrogen Alfa (ER-α)
by: Nurlelasari Nurlelasari, et al.
Published: (2023-03-01)

CADD-based discovery of novel oligomeric modulators of PKM2 with antitumor activity in aggressive human glioblastoma models
by: Maia Cabrera, et al.
Published: (2025-02-01)

Multipotent Effect of Clozapine on Lipopolysaccharide-Induced Acetylcholinesterase, Cyclooxygenase-2,5-Lipoxygenase, and Caspase-3: In Vivo and Molecular Modeling Studies
by: Minhajul Arfeen, et al.
Published: (2025-01-01)

Phytochemical constituents analysis in laminaria digitata for Alzheimer’s disease: molecular docking and in-silico toxicity approach
by: Angelina Deva Adella Putri, et al.
Published: (2024-12-01)

In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
by: Halim Sobia Ahsan, et al.
Published: (2021-03-01)

Integrative computational approaches for designing novel alpha-glucosidase inhibitors based on curculigoside A derivatives: Virtual screening, molecular docking, and molecular dynamics
by: Aiyi Asnawi, et al.
Published: (2024-04-01)

Searching for New Antibacterial Compounds Against <i>Staphylococcus aureus</i>: A Computational Study on the Binding Between FtsZ and FtsA
by: Alba V. Demesa-Castañeda, et al.
Published: (2024-11-01)

Discovery of anti-Ebola virus multi-target inhibitors from traditional Chinese medicine database using molecular screening, biophysical investigation, and binding free energy calculations
by: Abbas Khan, et al.
Published: (2025-02-01)

Discovery of Anti-inflammatory Peptides from Channa argus Using Virtual Screening, Molecular Docking, and Cell Model
by: XIANG Huan, LU Meiming, CHEN Shengjun, HUANG Hui, HU Xiao, ZHAO Yongqiang, WEI Ya
Published: (2024-12-01)

Sertraline as a Multi-Target Modulator of AChE, COX-2, BACE-1, and GSK-3β: Computational and In Vivo Studies
by: Minhajul Arfeen, et al.
Published: (2024-11-01)

Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations
by: Antonio Curcio, et al.
Published: (2024-11-01)

In Silico Analysis of Triamterene as a Potential Dual Inhibitor of VEGFR-2 and c-Met Receptors
by: Stuart Lutimba, et al.
Published: (2024-12-01)

Anti-proliferating and antioxidant properties of Eriobotrya japonica fruit in human breast cancer cells combined with in silico study
by: Astri Arnamalia, et al.
Published: (2024-12-01)

Antiviral activity of Humulus lupulus (HOP) aqueous extract against MERS-CoV and SARS-CoV-2: in-vitro and in-silico study
by: Thamer Ahmed Bouback, et al.
Published: (2023-03-01)

In silico binding role of flavonoids as SARS-CoV-2 main protease (Mpro) inhibitors: A dataset of molecular docking simulation-based high-throughput virtual screening (HTVS)Mendeley Data
by: Mariyam Eema, et al.
Published: (2025-04-01)

Phytochemical profiling, molecular docking, and ADMET evaluation of essential oils from Anaphalis busua and Anaphalis margaritacea in Uttarakhand's Himalayan Terrain
by: Ananya Bahuguna, et al.
Published: (2024-11-01)

Identification of AChE targeted therapeutic compounds for Alzheimer’s disease: an in-silico study with DFT integration
by: Kalpana Rawat, et al.
Published: (2024-12-01)

In Silico Evaluation of Potential NDM-1 Inhibitors: An Integrated Docking and Molecular Dynamics Approach
by: Eduvan Valencia, et al.
Published: (2024-12-01)

In silico molecular docking and molecular dynamic simulation of agarwood compounds with molecular targets of Alzheimer’s disease  [version 2; peer review: 2 approved, 1 not approved]
by: Tewin Tencomnao, et al.
Published: (2024-12-01)

Curcumin: Synthesis optimization and in silico interaction with cyclin dependent kinase
by: Ahmed Mahmood, et al.
Published: (2017-09-01)

In silico (Eco)toxicology and molecular docking of halogenated and oxygenated rotenoid derivatives
by: Damião Sampaio de Sousa, et al.
Published: (2023-12-01)

The potential of Mitragyna speciosa leaves as a natural source of antioxidants for disease prevention
by: Arief Ihsanul, et al.
Published: (2024-09-01)

Evaluating the insecticidal potential of alkaloids for the management of Thrips palmi: in vivo and in silico perspectives
by: Shyam Kumar Gupta, et al.
Published: (2024-11-01)

In Silico and In Vitro Investigation of Cytotoxicity and Apoptosis of Acridine/Sulfonamide Hybrids Targeting Topoisomerases I and II
by: Mohamed Badr, et al.
Published: (2024-11-01)

Michelia Alba Flower Oil Components as Tyrosinase Inhibitors: In Silico Study
by: Paundra Rizky Pratama, et al.
Published: (2022-01-01)

An in-silico approach to target multiple proteins involved in anti-microbial resistance using natural compounds produced by wild mushrooms
by: Gagandeep Singh, et al.
Published: (2024-12-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
by: Emma D. Frost, et al.
Published: (2024-11-01)

A galantamine–curcumin hybrid lacks the depressant side effect of acetylcholinesterase inhibitors
by: Ivanka Kostadinova, et al.
Published: (2024-12-01)

Recent Applications of In Silico Approaches for Studying Receptor Mutations Associated with Human Pathologies
by: Matteo Pappalardo, et al.
Published: (2024-11-01)

In silico approach in the development of structural analogues of resveratrol with improved distribution in the central nervous system
by: Mitrović Darko, et al.
Published: (2024-01-01)